Janet Pope
2 years 11 months ago
#Hope for people with #SLE
Insights from #ACR23
#Lupus #nephritis - half the oral #prednisone is = to 1 mg/kg induction after IV #solumedrol LESS PRED
#Anifrolimumab reduces similarly skin, jts, other common organs in #SLE RCTS APPROX 2X improvement vs PBO
@RheumNow @ACRheum https://t.co/OtdfTxZxr4
David Liew drdavidliew
2 years 11 months ago
As per #ACR23 ABST0433, what % of RA patients on US Medicare are on a DMARD within 1y of diagnosis?
I'm not talking your choice of b/tsDMARD.
I'm talking any cs/b/tsDMARD of any sort.
Hear from @JihaRheum to skip to the answer:
https://t.co/lI2M20JWKC
Truly stunning. @RheumNow
sheila
2 years 11 months ago
Frail pts with SLE is associated with 🔸prolonged hospitalizations (28.89%), 🔸significantly higher in-pt mortality (2.88%)
🔸fewer days-to-readmission (59.8%)
vs. non-frail pts with SLE
(CLeung et al)
Screen your SLE pts for frailty too.
#ACR23 ABST2590 @RheumNow https://t.co/c4YP5h2ypn
sheila
2 years 11 months ago
INSIST trial: MMF vs Tac in SS-ILD
N=25 pts
👉No significant diff between MMF & TAC in mean change in FVC at 24 weeks [2.52%, 95% CI (-10.3 to 5.18)p=0.500]
👉No SAEs noted in both grps
Larger studies w/ longer ffup needed.
#ACR23 ABST2595 @RheumNow https://t.co/cqpnxyMDmv
Lisa 🐳🗺🧭 rheumarhyme
2 years 11 months ago
I think crown belongs to the 🐱💜 🤗Top Influencers of #ACR23 👉 @ACRheum @rheum_cat @RheumNow @drdavidliew @EBRheum @realcc @KDAO2011 https://t.co/UfNdj8u7cP via @symplur https://t.co/b71OeZS7Jj
Nouf Al hemmadi
2 years 11 months ago
Dr. @Janetbirdope has the best quotes ever ‘ if its ain’t broke, don’t fix it, just leave it alone’ 🤷🏻♀️
IGg4 is very interesting , could just be reacting / secondary to an underlying phenomenon?
https://t.co/hueCJuYI32
@RheumNow
#ACR23, Daily recap.
Dr. John Cush RheumNow
2 years 11 months ago
Sex bias in RA: time to stop blaming hormones?
https://t.co/uPq87r4Ndv https://t.co/Yleu2LDV3g
Dr. John Cush RheumNow
2 years 11 months ago
Psoriatic Arthritis Topic Panel https://t.co/oQKqtxoyX0
Dr. John Cush RheumNow
2 years 11 months ago
Daily Recap - WEDNESDAY https://t.co/T6m444VPhk
Dr. John Cush RheumNow
2 years 11 months ago
SpA Sleuths: The Case of Undiagnosed IBD #ACR23
As rheums, we are medical detectives investigating complex and often elusive autoimmune and inflammatory conditions.
https://t.co/eRxlaoohbi https://t.co/dtXcCXKXql
Dr. John Cush RheumNow
2 years 11 months ago
Watch: Another TYK2 Ticks the Boxes
Dr. Janet Pope discusses late-breaking abstract L12 presented at #ACR23.
https://t.co/1SGuIFOWt6 https://t.co/tb4LRbmfiI
We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for nearly 3 years, but there has been relatively little to say about how to treat it. To date there have been over twice as many publications about VEXAS (263 publications) as there have been patients described with respect to treatment strategies (116 patients). One of the late breaking abstracts may finally have rectified this imbalance.
Should rheumatologists be counseling patients on cervical cancer prevention and screening? The data from Abstract #1479 at ACR Convergence 2023 suggests that this should be an important conversation with our female lupus patients.
Dr. John Cush RheumNow
2 years 11 months ago
#ACR23 – Day 1 Report
The day began with a bang with the Year in Review that featured the sage insights of Drs. Philip Seo and Tomas Mustelin about the scientific and clinical rheumatology highlights from the past year.
https://t.co/a79M2boHRH https://t.co/5P18ybazGK
